p14ARF interacts with N-Myc and inhibits its transcriptional activity

Stefano Amente1, Barbara Gargano, Daniel Diolaiti

  • 1Department of Structural and Functional Biology, University of Naples Federico II, Naples, Italy.

FEBS Letters
|February 10, 2007
PubMed

Insights

The human p14(ARF) protein interacts with N-Myc, inhibiting its transcriptional activity. This interaction, crucial for neuroblastoma cells, involves specific protein regions and affects N-Myc localization within the cell nucleus.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • The transcription factor N-Myc plays a critical role in cell proliferation and differentiation.
  • Dysregulation of N-Myc is implicated in various cancers, particularly neuroblastoma.
  • Understanding N-Myc regulation is essential for developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the interaction between human p14(ARF) and N-Myc.
  • To identify the specific regions involved in this interaction.
  • To elucidate the functional consequences of p14(ARF)-N-Myc binding on N-Myc activity and localization.

Main Methods:

  • In vivo association studies to confirm p14(ARF)-N-Myc interaction.
  • Site-directed mutagenesis to map the interaction domains.
  • Cellular localization studies using immunofluorescence in SK-N-BE neuroblastoma cells.
  • Over-expression studies to assess functional impact.

Main Results:

  • Human p14(ARF) directly associates with N-Myc in vivo.
  • A specific region (amino acids 140-300) of N-Myc, including the N-Myc BoxIII, is essential for p14(ARF) binding.
  • p14(ARF) over-expression causes N-Myc to delocalize from the nucleoplasm to the nucleoli.
  • The N-terminal region of p14(ARF) mediates binding to both N-Myc and c-Myc.

Conclusions:

  • p14(ARF) acts as an inhibitor of N-Myc-mediated transcriptional activation.
  • The interaction between p14(ARF) and N-Myc is structurally defined and influences N-Myc's subcellular localization.
  • These findings provide insights into the regulatory mechanisms of N-Myc in neuroblastoma and suggest potential therapeutic targets.

Related Concept Videos

Prokaryotic Transcriptional Activators and Repressors01:58

Prokaryotic Transcriptional Activators and Repressors

The organization of prokaryotic genes in their genome is notably different from that of eukaryotes. Prokaryotic genes are organized, such that the genes for proteins involved in the same biochemical process or function are located together in groups. This group of genes, along with their regulatory elements, are collectively known as an operon. The functional genes in an operon are transcribed together to give a single strand of mRNA known as polycistronic mRNA.
Transcription of prokaryotic...
25.2K
Prokaryotic Transcriptional Activators and Repressors01:58

Prokaryotic Transcriptional Activators and Repressors

No description available
10.3K
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.6K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.3K